DUAVEE Trademark

Trademark Overview

On Tuesday, February 5, 2013, a trademark application was filed for DUAVEE with the United States Patent and Trademark Office. The USPTO has given the DUAVEE trademark a serial number of 85840812. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, April 11, 2024. This trademark is owned by Pfizer Inc.. The DUAVEE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating symptoms associated with menopause; pharmaceutical preparations for the prevention of postmenopausal bone loss; pharmaceutical preparations for the treatment of vasomotor symptoms, namely, hot flashes, due to menopause
duavee

General Information

Serial Number85840812
Word MarkDUAVEE
Filing DateTuesday, February 5, 2013
Status800 - REGISTERED AND RENEWED
Status DateThursday, April 11, 2024
Registration Number4544493
Registration DateTuesday, June 3, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating symptoms associated with menopause; pharmaceutical preparations for the prevention of postmenopausal bone loss; pharmaceutical preparations for the treatment of vasomotor symptoms, namely, hot flashes, due to menopause

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 9, 2013
Primary Code005
First Use Anywhere DateMonday, February 3, 2014
First Use In Commerce DateMonday, February 3, 2014

Trademark Owner History

Party NameWYETH LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10001-219
Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, February 8, 2013NEW APPLICATION ENTERED
Saturday, February 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 11, 2013ASSIGNED TO EXAMINER
Wednesday, March 13, 2013SUSPENSION LETTER WRITTEN
Wednesday, March 13, 2013LETTER OF SUSPENSION E-MAILED
Wednesday, March 13, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 26, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, March 26, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 26, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 2, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2013ASSIGNED TO LIE
Tuesday, April 9, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 16, 2013TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, April 22, 2013ASSIGNED TO PETITION STAFF
Wednesday, April 24, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 2, 2013CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, May 14, 2013PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 20, 2013SOU TEAS EXTENSION RECEIVED
Friday, December 20, 2013SOU EXTENSION 1 FILED
Thursday, March 20, 2014USE AMENDMENT FILED
Friday, December 20, 2013SOU EXTENSION 1 GRANTED
Tuesday, December 24, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 20, 2014TEAS STATEMENT OF USE RECEIVED
Thursday, April 10, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 11, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, April 21, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 30, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, May 1, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 3, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, June 18, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 3, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 6, 2019TEAS SECTION 8 & 15 RECEIVED
Friday, October 18, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, October 18, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, October 18, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, January 23, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, March 18, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 19, 2020POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Thursday, April 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, June 3, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, November 30, 2023TEAS SECTION 8 & 9 RECEIVED
Thursday, April 11, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 11, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 11, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, April 11, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

duavee pharmaceutical preparations symptoms menopause treatment vasomotor namely flashes loss prevention